The Wegovy Vision Loss Lawsuit is an active lawsuit See If You Qualify Multiple studies and reviews suggest that individuals taking semaglutide, the active ingredient in Wegovy (semaglutide), may face an increased risk of a rare condition known as nonarteritic anterior ischemic optic neuropathy (NAION), which causes sudden vision loss
Participants are screened, monitored, counseled, and followed up with regularly
If that sounds like you, our Healthy Aging Supplements collection is a natural next stop
See the full starting-price breakdown before you enter payment info
On MyLupusTeam, more than 223,000 people with lupus come together to ask questions, give advice, and share their stories